The Allstate Co. (NYSE:ALL – Get Free Report) declared a quarterly dividend on Thursday, November 14th,RTT News reports. Stockholders of record on Friday, November 29th will be paid a dividend of 0.92 per share by the insurance provider on Thursday, January 2nd. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Friday, November 29th.
Allstate has increased its dividend by an average of 18.1% annually over the last three years and has raised its dividend annually for the last 14 consecutive years. Allstate has a payout ratio of 19.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Allstate to earn $19.14 per share next year, which means the company should continue to be able to cover its $3.68 annual dividend with an expected future payout ratio of 19.2%.
Allstate Trading Up 2.9 %
ALL opened at $207.80 on Wednesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company has a market cap of $55.03 billion, a price-to-earnings ratio of 13.46, a price-to-earnings-growth ratio of 1.80 and a beta of 0.48. The firm has a 50 day simple moving average of $191.99 and a 200 day simple moving average of $178.36. Allstate has a fifty-two week low of $134.17 and a fifty-two week high of $208.23.
Insider Buying and Selling
In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.80% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on ALL. Raymond James upped their price target on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a report on Friday, October 4th. Barclays upped their price target on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a report on Thursday, October 31st. StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. Keefe, Bruyette & Woods increased their target price on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. Finally, Wells Fargo & Company increased their target price on shares of Allstate from $175.00 to $186.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $217.19.
Check Out Our Latest Stock Analysis on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- Using the MarketBeat Dividend Yield Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 2 Essential Data Center Solutions Providers Riding the AI Boom
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.